SCHEMBL20127650

SCHEMBL20127650

c1ccc2c(c1)oc1c(-c3c4ccccc4c(-c4ccc(-c5ccc6c7ccccc7c7ccccc7c6c5)cc4)c4ccccc34)c3oc4ccccc4c3cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.41
PLA2G2A P14555 4/20 0.38
PLA2G4A P47712 4/20 0.38
ALOX5 P09917 2/20 0.38
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
KMT2A Q03164 2/20 0.36
PGR P06401 1/20 0.35
DYRK1A Q13627 1/20 0.35
PTPN1 P18031 3/20 0.34
MAOB P27338 1/20 0.34
PLA2G10 O15496 1/20 0.34
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127641 0.94 AHR (0.42) AHRPLA2G2APLA2G4AALOX5KDM4E
SCHEMBL20127658 0.91 PLA2G2A (0.41) AHRPLA2G2APLA2G4AALOX5KDM4E
SCHEMBL20127659 0.91 MAPT (0.44) AHRPLA2G2APLA2G4AALOX5KDM4E
SCHEMBL10122330 0.89 AHR (0.44) AHRPLA2G2APLA2G4AALOX5KDM4E
SCHEMBL20127449 0.89 AHR (0.37) AHRPLA2G2APLA2G4AALOX5KDM4E
SCHEMBL10122342 0.85 AHR (0.46) AHRPLA2G2APLA2G4AALOX5KDM4E
SCHEMBL20127421 0.85 ALOX5 (0.43) AHRPLA2G2APLA2G4AALOX5KDM4E
SCHEMBL10122350 0.85 ESR1 (0.40) AHRPLA2G2APLA2G4AALOX5ALDH1A1
SCHEMBL10122631 0.85 PLA2G2A (0.41) AHRPLA2G2APLA2G4AALOX5KDM4E
SCHEMBL20127616 0.85 PLA2G2A (0.41) AHRPLA2G2APLA2G4AALOX5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 AHR 2558/4885PLA2G2A 2960/4885PLA2G4A 3780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.